vasopressin v1a receptor

L-371,257 是催产素受体的竞争性拮抗剂，pA2 为 8.4，Ki 为 19 nM。 L-371,257 对加压素受体 1a 的 Ki 值为 3.7 nM。

LIT-001 是非肽类催产素受体激动剂，EC50为55 nM，Ki 为226 nM。它可改善孤独症小鼠模型的社交互动。

SRX246 has no interaction at V1b and V2 receptors. SRX246 shows negligible binding at 64 other receptors classes, including 35 G-proteincoupled receptors. SRX246 is a potent and CNS-penetrant vasopressin 1a (V1a) receptor antagonist (Ki=0.3 nM for human V

VNA-932 is an agonist of the vasopressin V2-receptor (IC50: 80.3 nM and 778 nM in human-V2 binding and V1a binding assay).

Conivaptan, a non-peptide inhibitor of antidiuretic hormone, was approved for hyponatremia caused by the syndrome of inappropriate antidiuretic hormone (SIADH), there is also some evidence that it may be effective in heart failure. Conivaptan inhibits sub

vasopressin V1A receptor antagonist

L-368899 is a non-peptide and orally active antagonist of oxytocin receptor (IC50: 8.9 nM). It displays 40-fold selectivity over vasopressin V1a and V2 receptors (IC50: 370 and 570 nM respectively).

RWJ 676070 is an antagonist of vasopressin V1A V2 receptor.

Selepressin, an analog of vasopressin, is a potent, selective vasopressin V1a receptor agonist.

Selepressin acetate(876296-47-8 Free base) 是一种 vasopressin 类似物，是一种有效的选择性 vasopressin V1a 受体激动剂。

SRX 251, a vasopressin V1a receptor antagonist, is used potentially for the treatment of primary dysmenorrhea.

YM 218 is a novel, potent, selective antagonist of nonpeptide vasopressin V1A receptor.

YM 471 is a non-peptide arginine vasopressin (AVP) V1A and V2 receptor antagonist with oral activity.

Conivaptan hydrochloride (Vaprisol) 是一种口服有效的加压素 V2 和 V1A 受体拮抗剂，用于治疗高血容量性低钠血症和正常血容量。

d[Cha4]-AVP TFA 是一种有效的选择性加压素 (AVP)V1b 受体激动剂，对人V1b 受体的Ki 为 1.2 nM。d[Cha4]-AVP TFA 对 V1b 受体的选择性高于对人类 V1a 受体、V2 受体和催产素受体。

Val9-Oxytocin为完全抗拮抗加压素(1a)受体的化合物，其结构上是Oxytocin的衍生物，特点在于Gly9位点被Val9取代。

(d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin (d(CH2)5[Tyr(Me)2, Dab5]AVP)作为针对加压素受体V1a的特异性拮抗剂，具有pA2值为6.71。

Invopressin (Compound 42)，一种vasopressin V1A 受体部分激动剂（EC50: 1.0 nM），主要应用于肝硬化相关症状如细菌性腹膜炎、HRS2 及难治性腹水的研究。

Selective vasopressin V1B receptor agonist (Ki values are 0.16, 64, 100 and 3800 nM for V1B, oxytocin, V2 and V1A receptors respectively). Displays weak antidiuretic, vasopressor and in vitro oxytocic activities.

Potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligible vasopressor activity in vivo.

d[Cha4]-AVP acetate(500170-27-4 free base) 是一种有效的选择性人血管加压素 V1B 受体激动剂（V1B、V1A、催产素和 V2 受体的 Ki 值分别为 1.2、151、240 和 750 nM）。刺激 ACTH 和皮质酮分泌，并在体内表现出微不足道的血管加压活性。

Selective vasopressin V1A receptor antagonist. Inhibits vasopressin and oxytocin-induced increases in intracellular calcium concentrations in vitro (IC50 values are 5 and 30 nM respectively). Exhibits potent and prolonged antivasopressor activity and indu